This CIRM grant has supported the development of a human cardiac tissue model that can revolutionize drug development in the pharmaceutical industry. The technology was spun out to create Organos, a leader in the investigation of drug effects on the heart. Organos will further develop the technology to improve drug discovery pipelines, preventing costly attrition, reducing uncertainty before clinical testing, and providing sorely needed disease models for more successful outcomes.